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Abstract
Background: Biological and sociocultural differences between men and women may play an important role in
medical treatment. Little is known about the awareness of these differences among general practitioners (GPs) and
if they consider such differences in their medical practice. The aim of this study was to explore GPs’ perception of
sex and gender aspects in medical treatment.
Methods: We conducted five focus group discussions (FGDs) with 29 physicians (mainly GPs) in Sweden. A
discussion guide with semi-structured questions was used. All FGDs were audio-recorded and transcribed word-by-
word. Data were analysed through inductive thematic analysis with no predetermined categories.
Results: Three main categories emerged from the data. The first category emphasised GPs’ experiences of sex
and gender differences in diagnosing and assessment of clinical findings. Medical treatment in men and women
was central in the second category. The third category emphasised GPs’ knowledge of sex differences in drug
therapy.
Conclusions: The GPs stated they had little knowledge of sex and gender differences in drug treatment, but
gave multiple examples of how the patient’s sex affects the choice of treatment. Sex and gender aspects were
considered in diagnosing and in the treatment decision. However, once the decision to treat was made the
choice of drug followed recommendations by local Drug and Therapeutics Committee, which were perceived to
be evidence-based. In the analysis we found a gap between perceived and expressed knowledge of sex and
gender differences in drug treatment indicating a need of education about this to be included in the curriculum
in medical school and in basic and specialist training for physicians. Education could also be a tool to avoid
stereotypical thinking about male and female patients.
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Background
There are biological differences between men and
women that may influence medical treatment [1]. Ac-
knowledging this might lead to better health care and
treatment outcomes for both men and women. Women
are prescribed more medicines than men in most ages,
even if hormonal treatments such as contraceptives or
hormonal replacement therapy are excluded [2–4]. One
reason might be that women have more contact with
primary health care [5–7]. There are conflicting results
on whether the patient’s sex is associated with delay in
diagnosing serious conditions such as malignant and
chronic diseases [5, 8, 9]. Health care seeking behaviour
differs between men and women due to both sex (bio-
logical) and gender (behavioural socioculturally related)
differences [7, 10]. As health care consultations often re-
sult in a prescription, health care seeking behaviour may
in itself influence drug utilisation [11]. Overall, women
have been shown to suffer from adverse drug reactions
(ADRs) to a higher degree than men [12, 13]. Several
drugs have different patterns of adverse effects in men
and women [14, 15]. Effective dose may vary as there are
pharmacokinetic and pharmacodynamics differences be-
tween men and women [16, 17]. Teaching about sex and
gender differences in health care seeking patterns, drug
utilisation and clinical pharmacology have varied over
time and between different medical schools. It is unclear
how much general practitioners (GPs) know about these
differences and how much attention they pay to them.
The aim of this study was to explore GPs’ perception of
sex and gender aspects in medical treatment.
Methods
Study design
We used a qualitative research approach as this meth-
odology is well suited for studying perceptions and ex-
periences of different phenomenon [18]. Focus group
discussions (FGDs) were chosen as data collection
method since they are particularly useful when the aim
is to gain different views on a specific topic [18–20].
The group process in a FGD drive the informants to
concretise ideas and to find mutual experiences, that
may not have been expressed in another context [19].
In contrast to a series of individual interviews, partici-
pants in a FGD will hear each other’s responses and
can thus give additional comments and develop and
supplement their answers [19, 20].
Setting and sample
Since we wanted information-rich cases, the informants
were selected by using strategic sample selection [18].
Most health care and medical treatment are carried
out by GPs and GPs face patients with a large variety
of conditions and diagnoses [21]. The informants
were recruited from health centres in different geo-
graphic areas in Sweden where the physicians were
interested in participating in FGDs about treatment of
men and women. These factors were considered to
provide a good basis for discussions related to the re-
search questions.
In Sweden, health care is publicly funded and pro-
vided by county councils. Swedish GPs work in public
or tax-financed private health centres, which are often
multidisciplinary with physicians and registered nurses
and sometimes also midwives, gynaecologists, physio-
therapists and psychologists. In contrast to many other
European countries, the GPs do not have a gatekeeper
function and the patients are allowed to consult other
specialists without a referral. However, the GPs are
expected to have the overall responsibility for their
patients [22].
Data collection
The heads of three health centres from different socio-
economic areas in an urban area of Sweden were con-
tacted and informed about the study. All three agreed to
participate and were asked to recruit four to eight physi-
cians within their health centre. The FGDs were carried
out in the autumn of 2012. The third FGD did not give
any new information and thoughts related to the aim of
the study. Therefore we performed two additional FGDs
to see if there were any other perspectives and ideas
among GPs in other, non-urban, areas of Sweden. These
two FGDs were carried out in the spring of 2013.
However, no additional information was obtained and
thus we assumed that saturation was reached. In all,
29 informants, both men and women at different ages
participated in the FGDs. By definition, GPs are spe-
cialists in family medicine. In our study, most partici-
pating physicians were specialised in family medicine
but there were also interns and resident physicians
among the participants (Table 1). For simplicity rea-
sons, we refer to all physicians who participated in
the FGDs as GPs.
Two researchers (DL and KH/LK) were present during
the FGDs, as moderator and observer. The moderator’s
role was to lead the informants in the FGDs, to ensure
that they discussed the questions among themselves and
not just with the moderator, and that everyone had the
opportunity to speak. The observer supported the mod-
erator by asking probing questions [20].
Before the FGD started the informants were informed
about the study and that their participation was volun-
tary and their confidentiality guaranteed. All informants
signed a consent form. A semi-structured discussion
guide (Table 2) was used throughout the FGDs [18]. The
discussion guide was pre-tested to see that no integrity
violating questions were used.
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Data analysis
All FGDs were audio-recorded and transcribed word-by-
word by two researchers (DL and KH). An inductive
thematic analysis with no predetermined categories was
performed [18] in a stepwise manner (Table 3).
Ethical approval
The study has received ethical approval from the Regional
Ethics Committee at Karolinska Institutet, Sweden
(ref. no. 2014/2161-31/5).
Results
Three main categories emerged from the data after ana-
lysis. Categories and sub categories are presented below
(Table 4).
Experience of sex and gender differences in diagnosing
and assessment of clinical findings
a. Sex differences in symptomatology, diseases and
morbidity
The GPs described that patterns of disease differ be-
tween men and women. For diagnoses with obvious sex
differences such as urinary tract infections, the GPs said
they considered the patient’s sex. Some symptom diag-
noses such as pain were perceived to be more common
in women. Women were described as having more mor-
bidity than men, partly due to reproductive health. The
GPs experienced that more women than men needed
short- and long-term sick leave.
The GPs stated that presentation of diseases and
symptoms may differ between the sexes. Women were
perceived to express a more diffuse symptomatology, es-
pecially in cardiovascular diseases, and being more diffi-
cult to diagnose. In depression, the GPs experienced that
women expressed the expected symptoms of being sad
while men expressed more aggression and irritability.
The GPs claimed that, as diseases may present differ-
ently in men and women and some diagnoses are more
common in one sex, the patient’s sex do affect how they
examine, decide on a diagnosis and consider differential
diagnoses, investigations and treatment.
That you interpret certain parts of the medical history
differently if it concerns a man or a woman. That you
deduce the cause differently without really evaluating
what they [the patients] say. (Female8 FGD2, in
response to the question how lack of awareness of
sex and gender could affect diagnosing)
Table 2 Discussion guide with topics for the FGDs
Introductory question about gender equality and treatment in general
1. How do you reason about gender equality in your work regarding
the care of patients?
Questions more specifically about medicines
2. In what way does the patient’s sex affect how you reason about
treatment/medication?
3. Do you believe that female and male patients expect different
treatment/medication? How/in which way?
4. Can differences in behavior between male and female patients’ result
in different treatment/medication?
5. We know that there are certain differences between the sexes where
men and women sometimes are treated with different medications in
spite of the same diagnosis, and that women receive more
medications than men. What are your reflections on this?
6. Do you believe that you as physicians can affect the sex differences in
drug utilisation? How/in which way?
Concluding questions
7. How do you perceive your knowledge is regarding this topic?
8. How did you find it to discuss this topic?
Table 3 Description of the analysis process
1. Tapes, transcripts and field notes from the FGDs were listened to and
read repeatedly to get a good grasp of the material.
2. Sections of text in the transcripts, focusing on the research question,
were grouped into two main categories; “Sex and gender aspects on
patient visit” and “Patient sex in relation to drug treatment”.
3. The sections of text in each main category were summarised and
grouped by content into preliminary subcategories.
4. The next step was to find related patterns within each preliminary
subcategory. Sections of text were moved between subcategories
and new subcategories were formed.
5. The subcategories were grouped into three categories (Table 4).
6. Quotes were selected to illustrate the categories. These quotes were
translated to English by the authors. Repetitions and unnecessary
words such as humming were removed. To ensure that the sense in
the content wasn’t changed in the translation, the quotes were cross
translated back to Swedish by a native English speaking person.














Specialist in family medicine 19 66
Resident 4 14
Intern/Rotation 4 14
Specialist in internal medicine/cardiology 2 7
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b. GPs’ views on different health care seeking behaviour in
men and women
The GPs experienced that women are seeking more
health care than men, particularly for urgent medical
needs. However, the GPs had the impression that youn-
ger men were more inclined to seek health care than
older men and that the sex gap in health care seeking
behaviour is diminishing. Some GPs reflected on the risk
of men receiving less health care than women due to
health care seeking behaviour.
If you consider that men seek [health care] less often, it
might be more equal to actively make appointments
with men who do not seek health care. But I don’t
think about this actively. (Male5 FGD2)
The GPs believed that women had a lower threshold
to seek health care. One suggested explanation was that
women are more used to contacts with health care be-
cause they take a greater responsibility for the entire
family’s health. Another explanation mentioned was that
there are more screening programs for women, which
will increase the contacts with health care. Men were
perceived to have a higher threshold for seeking health
care. Some GPs said that men often had been sent there
by their mother or partner. A perception of men as
hearty, strong and able to look after themselves was
expressed.
Men are big and strong and have a higher threshold to
seek health care. I can imagine that there are
differences. But it is nothing that we possibly can affect
that much. (Female13 FGD3)
In view of this, the GPs regarded a man seeking for ur-
gent medical needs to be more likely to have a genuine
health problem. While some GPs found men to have
longer delays in seeking health care, maybe due to ignor-
ing their symptoms in order to not appear weak, others
did not have this experience.
I find myself thinking, “Oh my God, this person has
not sought medical attention,” and that is almost
always a man who has been having a symptom, of a
cancer for example, far too long. I have never
experienced an equivalent situation when the patient
is female. (Male5 FGD2)
Men and women were perceived to seek health
care due to different causes. GPs perceived that more
women made appointments due to problems with de-
pressed mood. There was no consensus on whether
depression is more common in women, if men ig-
nore such symptoms or if it is more socially accepted
for women to seek medical help for depression. Gen-
erally, when a man made an appointment for depres-
sive symptoms he was perceived to have a more
severe depression, assumed to have delayed making
an appointment, and was thus started on treatment
immediately.
But of course I’m thinking that I should just simply
start from how the person feels, not if it is a man or a
woman. But I can imagine that I unconsciously would
expect a man to be more depressed before he seeks
medical care for his depression. And then maybe he
would get medication faster compared to a woman.
(Male4 FGD2)
Men were perceived to describe their medical prob-
lems briefly and to often seek medical attention for a
specified problem while women were perceived to have
more diverse problems and to describe them more thor-
oughly. As men were perceived to delay contact with
health care, there was a concern among the GPs that
they risked missing morbidity in men.
c. Influence of sex on the interaction between GP and patient
According to the GPs, both physician’s and patient’s sex
influenced the physician-patient interaction. Some found
it easier to handle a patient of their own sex, while
Table 4 Categories and subcategories of Swedish GPs knowledge and views on how patient’s sex influence practice
Category Subcategory
1. Experiences of sex and gender differences in diagnosing
and assessment of clinical findings
a. Sex differences in symptomatology, diseases and morbidity
b. GPs’ views on different health care seeking behaviour in men and women
c. Influence of sex and gender on the interaction between GP and patient
2. Medical treatment in men and women a. Making treatment decisions
b. GPs’ views on patients’ attitudes to medicines
c. Adverse drug reactions in men and women
3. Knowledge of sex differences in drug therapy a. GPs’ expressed knowledge
b. GPs’ expressed ignorance
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others considered personal chemistry and individual fac-
tors to be of greater importance. Also, their own preju-
dices about the patient’s problem were proposed to be a
factor in the interaction and that their own sex was per-
ceived to be of importance particularly for patients with
sex related disorders. The GPs knew that most nurses,
who book the GP appointments, also assumed this and
booked accordingly, for example a male patient with a
prostate problem was sent to a male GP. Also, patients
could request to see a male or female physician. Some
GPs believed that the physician’s sex played a less im-
portant role for male patients as men are used to being
cared for by women.
A belief among the GPs was that there is a difference
in how male and female physicians treat patients. They
experienced that female GPs attracted patients with
more multi-morbidity and social problems as they were
expected to be more caring.
Some GPs believed they treated men and women in
the same way while others claimed to speak differently
and ask different questions to men and women, putting
more focus on the family situation with women and on
the work situation with men.
I think we speak differently with men and women,
maybe focusing more on family problems and all that
with a woman, possibly a bit more than you do with a
man, perhaps unconsciously. I think in any case that
we speak different “languages” with men and women,
perhaps without even thinking about it. (Female13
FGD3)
Medical treatment in men and women
a. Making treatment decisions
The GPs described that choice of treatment was based
both on their own and the patient’s preferences and
opinions. They reported that individual factors such as
personality had a larger impact than the patient’s sex on
the outcome of the visit. The GPs believed that their
own sex might influence their view of a patient and their
prescribing, but again, that other factors such as experi-
ences and opinions had more influence.
Yes sex probably affects in some way, the question is
how much. I think maybe personality affects more
than sex does… (Male8 FGD4)
On the issue of using pharmacological treatment or not,
the GPs believed that there might be differences based on
whether the patient is a man or a woman. Less prescribing
of analgesics to men as they were considered to be able to
endure pain was given as example. Treatment in depres-
sive disorders was given as another example where treat-
ment decision was affected by patient’s sex.
When thinking about pain you might assume that a
man can endure some pain, that you are not as
inclined to prescribe painkillers to a man as to a
woman. Or maybe you feel a bit more sorry for the
woman. (Male8 FGD4)
When treating more diffuse, unspecific medical condi-
tions in women (see also 1 a. Sex differences in symptom-
atology, diseases and morbidity), the GPs described that
they did not really know what to do. They said they tried
to help the patient and offer some treatment or action,
often prescribing pills although they were aware of that
this was not always the best solution.
There may be more unexplored diseases affecting
women, or, well, more unspecific symptom patterns
that we do not really have an understanding of… But
it’s very easy when you feel frustrated and want to
help that you think, “Well, but there must be some
medicine for this”, and there is usually something you
can prescribe. (Female17 FGD5)
The GPs said they followed guidelines and recommen-
dations to a great extent and used drugs from recommen-
dation lists particularly from the Drug and Therapeutics
Committees (DTCs). The recommendation list was de-
scribed as a good guidance and the GPs believed it to
consider sex and gender aspects. Some GPs felt limited
by the recommendations as they offer a limited choice
of drugs.
The GPs said that they don’t take patient’s sex into ac-
count when deciding on type of drug therapy. They
thought they didn’t make any differences between men
and women and that they prescribed the same drug for
patients with the same diagnosis. Urinary tract infection
was raised as an exception in which the patient’s sex de-
termined the treatment and men and women were
treated differently due to biological reasons. Another
situation when the patient’s sex became apparent was
during pregnancy.
If I diagnose two patients, a man and a woman, they
will get the same treatment regardless of sex. On
condition that everything is consistent. But on the road
to a diagnosis I might have missed that the woman is
little different, or the man is little different, if you
know what I mean. When I have come to the
conclusion that I should treat someone for a specific
disease then the sex is not relevant. (Male1 FGD1)
The GPs described that there are some physiological
differences between men and women they consider
when selecting drugs. However, patient’s sex was de-
scribed as one of several factors to take into account and
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the GPs held individual factors such as comorbidities
and age to be more important.
b. GPs’ views on patients’ attitudes to medicines
Male and female patients were perceived to have differ-
ent expectations of health care and treatment. Women
were considered to be more prone to accept suggestions
of medicines and more often express a desire to try
medicines, including herbals. Some GPs perceived men
to have a more negative attitude toward medicines, while
some perceived women to be more negative. Others ex-
perienced no sex differences in attitude to medicines.
According to the GPs, attitudes towards medication use
could depend on where in the country you live, particu-
larly if the area is rural or urban. Also ethnicity was
raised as a factor that influenced the patient’s view on
medicines.
The GPs felt that more women than men have precon-
ceived notions about medications and what they want or
don’t want to have. This was thought to be related to
women discussing their medications with others more
often than men do. Some GPs described that men were
more likely to accept the physician’s suggestions while
women were more likely to have concerns and want to
debate the suggestions.
There are many women who have said that “my friend
had that and it was horrible, I certainly do not want
to have it.” I know only one man who has said this.
(Male3 FGD2)
An experience among the GPs was that an increasing
number of patients were well informed about diseases
and treatments, regardless of the patient’s sex. However,
some GPs thought that men used to be better informed
than women but that this had changed. Higher level of
education was perceived to increase the likelihood of a
patient being well informed. To bring clippings from
magazines were considered to be typical for women.
I think it is more associated to profession than to sex.
Teachers and engineers, they are the most active in
retrieving information. They can carry a whole pile of
papers… (Male1 FGD1)
c. Adverse drug reactions in men and women
Some GPs said that they were not aware of sex differ-
ences in ADRs and that they did not think it might be
different in men and women. The GPs said that they
prescribed some drugs to a lesser extent to one sex be-
cause of the risk of ADRs. Examples of this were avoid-
ance of beta blockers to men due to risk of impotence
or of diuretics to older men not to aggravate prostate
problems. The GPs also described that they sometimes
preferred a particular drug to a patient of one sex be-
cause they wanted to take advantage of some special
properties of the drug, for example diuretics to women
with hypertension and swollen ankles. Some GPs said
that they prescribe drugs according to recommenda-
tions but are more observant of potential ADRs in one
of the sexes.
I think that treatment of high blood pressure is
what is closest at hand, partly due to the
mechanism of action. If you have trouble with
water retention in your body, it’s usually a woman,
and then thiazides and diuretics may be the drugs
of choice. You think of it first because it lowers the
blood pressure, reduces the swelling in the body and
also has a certain preventive effect on osteoporosis,
well doesn’t it sound fine… However, if you are a
man about fifty-five to sixty and start taking
thiazides, then there is a risk that you may have to
start getting up at night because the prostate, that
you had no troubles with before, it might start to
cause problems. (Female1 FGD1)
The GPs said they used the same drug doses in men
and women. However, some GPs said they prescribed
lower doses of certain drugs to women, especially older
women, to reduce the risk of ADRs.
Doses, for example, you might not use as high doses to
a woman as to a man, especially if they are elderly. I
think women get more adverse effects, statistically
speaking, and that is often a matter of dosage.
(Female17 FGD5)
There were different views on sex differences in
ADRs. One view was that women have more ADRs
than men, while others thought women to report
more ADRs. Some GPs felt that women with ADRs
talked to their physician while men stopped taking
their medication. Regardless of approach, the GPs said
that they believed there were sex differences in ADRs
for certain substances. Statins and ACE inhibitors
were mentioned as examples. The GPs described that
there is a risk of misinterpreting symptoms that are
more common in one sex as ADRs. Muscle pain was
mentioned as an example of a common ADR of sta-
tins but also a symptom that is perceived to be more
common in women.
Women were perceived to be more sensitive to medi-
cines and often say that they were not able to tolerate
certain drugs. The GPs experienced women to want to
change treatment because of suspected ADRs more
often, requiring several changes before finding a well-
tolerated medicine.
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There is a perception that there are more women
[than men] who say they do not tolerate certain drugs,
and it can be diffuse side effects that we find it
difficult to relate to sometimes. (Male9 FGD4)
Knowledge of sex differences in drug therapy
a. GPs’ expressed knowledge
The GPs discussed the problem of many drugs being
poorly studied in women and that evidence on how to
treat women is sometimes lacking. The cardiovascular
area was considered the most explored. Knowledge of
sex differences in newer drugs, such as ACE inhibitors
and statins, were considered to be better than for older
drugs. The GPs described that they tried to take known
sex differences into account when prescribing. Some
GPs recalled a lecture in medical school about sex differ-
ences in cardiovascular diseases, but otherwise could not
recollect receiving any education about sex differences
in drug therapy.
It is exactly at the moment of prescribing you
decide on what kind of medicine to choose,
regardless if the patient is a man or a woman. I
think we [GPs] in general have rather poor
knowledge, it’s not just me, I think everyone has.
And many drugs are not studied in both men and
women. In those cases where I know that there may
be sex differences I try to take it into consideration.
(Female17 FGD5)
It was emphasised that there was no evidence that
women and men should have identical treatment. How-
ever, the GPs said that they assumed that drugs help
equally well.
b. GPs’ expressed ignorance
The GPs rated their knowledge about sex differences as
low. In general, the GPs assumed that men and women
should be treated in the same way. They reasoned; if
there were differences between men and women in
ADRs this would have been noted and treatment recom-
mendations changed. As they treated men and women
in the same way there could not be any major differ-
ences. If there were large sex differences they would
treat differently. A need of more knowledge about
pharmacological treatments, where sex differences need
to be considered, was expressed.
So my last question about your knowledge of the
topic… (Moderator FGD4) Well as you notice,
completely non-existent. (Male9 FGD4) (Laughter) It
is low. (Male7 FGD4) You have said that a few
times. (Moderator FGD4) Non-existent to low.
(Male8 FGD4)
Discussion
To our knowledge, this is the first study exploring GPs’
perceptions on sex and gender aspects in medical treat-
ment. Our study do not analyse what physicians actually
do, which has been done earlier in studies conducted on
how GPs act when treating men and women with
standardised symptoms and showing that the sex of the
patient influence GPs diagnostic and management activ-
ities [23–25]. In our study, the GPs stated they had little
knowledge of sex differences in drug treatment. How-
ever, they gave several examples of how they considered
this in their drug prescription indicating the opposite.
The GPs also described sex differences in health care
seeking behaviour (i.e. women seeking more health care
than men), management (i.e. asking women more about
family situation) and morbidity (i.e. different prognosis
and presentation of diseases), differences that are in
agreement with scientific literature [26]. Most experi-
ences were not perceived by the GPs as proven and thus
not perceived as knowledge. In our analysis of the FGDs
we find a gap between the GPs perceived knowledge,
which was considered low, and the rather extensive ex-
amples the GPs gave reflecting actual knowledge and ex-
periences. This gap may indicate that education about
sex and gender aspects in medicine has been lacking
during their medical training [27] and in their continu-
ing medical education. The lack of education was inter-
preted by the GPs that there is a lack of evidence-based
knowledge or that the issue is of no importance.
The GPs claimed to treat men and women equally, but
in other contexts they expressed thoughts that were not
based on a gender equality perspective. Stereotypical
perceptions of men and women affected the GPs’
thoughts about diseases, diagnosis and differential diag-
noses. Physicians making medical decisions based on as-
sumptions and stereotypical thinking has also been
shown in other studies [28, 29]. This works as long as
patients act as their stereotypes with symptoms and be-
haviour, but when patients don’t, incorrect decisions
about treatment can be made. For example, there may
be a risk that the GPs underestimate the emergency level
of women’s diseases as well as over-treat men when pa-
tients do not seek health care according to their
stereotype.
During the FGDs it became obvious that sex and gender
considerations were made concerning diagnosis and deci-
sion to treat or not. That the sex of the patient influences
physicians diagnostic and management activities has been
shown in studies from the US and the UK [23, 24]. The
GPs in our study stated that once the decision to treat was
made, choice of drug followed recommendations from the
respective DTC. Since there is a pressure to follow the
recommendations from the DTC this is not surprising
[30]. However, this is in contrast to the study by Arber
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where fewer women with coronary heart disease were
found to be given appropriate medication [24]. Also in
Sweden, women with atrial fibrillation have been treated
with anticoagulants to a lower extent than men [31, 32].
The FGDs revealed a high trust in the recommended
treatment choices in accordance with a study of attitudes
to the recommendations in Stockholm where 81 percent
of prescribers found the DTC’s recommendations to be
trustworthy. Of interviewed patients 90 percent wanted
their doctor to follow the recommendations [30]. The
awareness of sex and gender differences for the recom-
mended drugs among the experts making the recommen-
dations has not yet been explored and may vary. While
there are sex specific recommendations in some medical
areas [33] this is not always the case.
Strengths and limitations
Given the design of the study, we were only able to get
data on what the GPs said they did; not what they actu-
ally do in practice. Still, a relationship between what
people say and do could be anticipated. To increase the
validity between “saying and doing” we frequently used
follow-up questions during the FGDs asking for concrete
examples of the participants’ way of acting [18]. Further-
more, FGDs are a suitable method to explore unreflected
topics, i.e. topics that one do not have thought about or
discussed that much [18–20]. Sex and gender issues in
drug treatment turned out to be an unreflected topic.
The method with FGDs where the informants interact
and help each other to explore and clarify their views,
ways that would be less easily accessible in individual in-
terviews, was thus preferable. Another strength of this
study was the participation of GPs with varying degrees
of professional experience, working in different geo-
graphic and socioeconomic areas of Sweden. Further-
more, the GPs did not seem to have any hesitations
about expressing conflicting opinions. Otherwise, it can
be a risk in FGDs that the participants modify their an-
swers either to please the researcher or to avoid conflicts
with other participants [20]. Nevertheless, these five
FGDs gave a rich and nuanced picture of GPs’ views on
sex differences related to drug treatment.
Conclusions
In this study of physicians (mainly GPs) working in pri-
mary care settings in different parts of Sweden, the phy-
sicians stated they had little knowledge of sex and
gender differences in drug treatment. Nevertheless, they
gave multiple examples of how the patient’s sex affects
the choice of treatment. The FGDs showed that GPs
considered sex and gender in diagnosing and deciding to
treat or not. However, once the decision to treat was
made, choice of drug followed recommendations from
the respective Drug and Therapeutics Committee as they
were believed to be evidence based and sex neutral. To
bridge the gap between perceived and expressed aware-
ness, education on sex and gender differences in drug
treatment needs to be included in the curriculum in
medical school and in basic and specialist training for
physicians. Education could also be a tool to avoid
stereotypical thinking about male and female patients.
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